Matches in DBpedia 2014 for { ?s ?p Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug. It is marketed as K-GLIM-1 by BLUE CROSS, Amaryl by Sanofi-Aventis, GLIMPID by Ranbaxy Laboratories(Cardiovascular) and GLIMY by Dr.Reddy's Labs.It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation.. }
Showing items 1 to 2 of
2
with 100 items per page.
- Glimepiride abstract "Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug. It is marketed as K-GLIM-1 by BLUE CROSS, Amaryl by Sanofi-Aventis, GLIMPID by Ranbaxy Laboratories(Cardiovascular) and GLIMY by Dr.Reddy's Labs.It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation.".
- Glimepiride comment "Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug. It is marketed as K-GLIM-1 by BLUE CROSS, Amaryl by Sanofi-Aventis, GLIMPID by Ranbaxy Laboratories(Cardiovascular) and GLIMY by Dr.Reddy's Labs.It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation.".